Podcasts about pharmacological

Branch of biology concerning drugs

  • 148PODCASTS
  • 224EPISODES
  • 34mAVG DURATION
  • 5WEEKLY NEW EPISODES
  • Sep 26, 2022LATEST
pharmacological

POPULARITY

20152016201720182019202020212022


Best podcasts about pharmacological

Latest podcast episodes about pharmacological

PaperPlayer biorxiv neuroscience
Mitochondria dysregulation contributes to secondary neurodegeneration progression post-contusion injury in human 3D in vitro triculture brain tissue model.

PaperPlayer biorxiv neuroscience

Play Episode Listen Later Sep 26, 2022


Link to bioRxiv paper: http://biorxiv.org/cgi/content/short/2022.09.23.509276v1?rss=1 Authors: Liaudanskaya, V., Fiore, N. J., Zhang, Y., Milton, Y., Kelly, M. F., Coe, M., Barreiro, A., Rose, V. K., Shapiro, M. R., Mullis, A. S., Shevzov-Zebrun, A., Blurton-Jones, M., Whalen, M. J., Symes, A. J., Georgakoudi, I., Nieland, T. J., Kaplan, D. L. Abstract: Traumatic Brain injury-induced disturbances in mitochondrial fission-and-fusion dynamics have been linked to the onset and propagation of neuroinflammation and neurodegeneration. However, cell-type-specific contributions and crosstalk between neurons, microglia, and astrocytes in mitochondria-driven neurodegeneration after brain injury remain undefined. We developed a human three-dimensional in vitro triculture tissue model of a contusion injury, composed of neurons, microglia, and astrocytes, and examined the contributions of mitochondrial dysregulation to neuroinflammation and progression of injury-induced neurodegeneration. Pharmacological studies presented here suggest that fragmented mitochondria released by microglia are a key contributor to secondary neuronal damage progression after contusion injury, a pathway that requires astrocyte-microglia crosstalk. Controlling mitochondrial dysfunction thus offers an exciting option for the development of therapies for TBI patients. Copy rights belong to original authors. Visit the link for more info Podcast created by PaperPlayer

Psychiatry.dev -  All Abstracts TTS
Pharmacological interventions for the treatment of disordered and problem gambling – PubMed

Psychiatry.dev - All Abstracts TTS

Play Episode Listen Later Sep 23, 2022


https://psychiatry.dev/wp-content/uploads/speaker/post-9938.mp3?cb=1663954206.mp3 Playback speed: 0.8x 1x 1.3x 1.6x 2x Download: Pharmacological interventions for the treatment of disordered and problem gambling – PubMed Review Nicki Dowling et al. Cochrane Database of Systematic Reviews.Full EntryPharmacological interventions for the treatment of disordered and problem gambling – PubMed

ACC CardiaCast
Cardiacast's PulseCheck: Rhythm Control Pharmacological Treatment Options for Patients with Atrial Fibrillation

ACC CardiaCast

Play Episode Listen Later Sep 22, 2022 11:25


“PulseCheck” is a new series within CardiaCast that is designed for nurses or allied healthcare professionals who are new, or new to cardiology, offering practical team-based solutions to the challenges that nurses and allied health professionals face every day. In these panel discussions, host Andrea Price MS, AACC brings together Bailey Estes MSN, AGNP-C, Adam Burget RN and Ayesha Ather, PharmD, BCPS, BCCP to explore best practices related to atrial fibrillation. In this episode, the focus is on rhythm control pharmacological treatment options for people with AFib.  

CNS Journal Club
Neuro-Pharmacological Study of Posaconazole for Glioblastoma: A Phase 0 Clinical Trial Protocol

CNS Journal Club

Play Episode Listen Later Sep 15, 2022 17:18


October 2022 Journal Club Podcast Neuro-Pharmacological Study of Posaconazole for Glioblastoma: A Phase 0 Clinical Trial Protocol To read the journal article: https://journals.lww.com/neurosurgery/Fulltext/2022/10000/Neuropharmacological_Study_of_Posaconazole_for.19.aspx Author: Alireza Mansouri, MD Guest Faculty: Ganesh Rao, MD Moderator: Jeffrey I. Traylor, MD Committee Co-chair: Rafael A. Vega, MD, PhD

ACC CardiaCast
Cardiacast's PulseCheck: Pharmacological Treatment Options for Patients with Atrial Fibrillation

ACC CardiaCast

Play Episode Listen Later Sep 15, 2022 11:39


“PulseCheck” is a new series within CardiaCast that is designed for nurses or allied healthcare professionals who are new, or new to cardiology, offering practical team-based solutions to the challenges that nurses and allied health professionals face every day. In these panel discussions, host Andrea Price MS, AACC brings together Bailey Estes MSN, AGNP-C, Adam Burget RN and Ayesha Ather, PharmD, BCPS, BCCP to explore best practices related to atrial fibrillation. In this episode, the focus is on pharmacological treatment options for people with AFib.  

PaperPlayer biorxiv neuroscience
Haloperidol-induced immediate early genes in striatopallidal neurons requires the converging activation of cAMP/PKA/DARPP-32 and mTOR pathways

PaperPlayer biorxiv neuroscience

Play Episode Listen Later Sep 13, 2022


Link to bioRxiv paper: http://biorxiv.org/cgi/content/short/2022.09.10.507436v1?rss=1 Authors: Onimus, O., Valjent, E., Fisone, G., Gangarossa, G. Abstract: Antipsychotics share the common pharmacological feature of antagonizing the dopamine 2 receptor (D2R) which is abundant in the striatum and involved in both the therapeutic and side effects of this drugs class. Pharmacological blockade of striatal D2R, by disinhibiting the D2R-containing medium-size spiny neurons (MSNs), leads to a plethora of molecular, cellular and behavioral adaptations which are central in the action of antipsychotics. Here, we focused on the cell type-specific (D2R-MSNs) regulation of some striatal immediate early genes (IEGs), such as cFos, Arc and Zif268. Taking advantage of transgenic mouse models, pharmacological approaches and immunofluorescence analyses, we found that haloperidol-induced IEGs in the striatum required the synergistic activation of A2a (adenosine) and NMDA (glutamate) receptors. At the intracellular signaling level, we found that the PKA/DARPP-32 and mTOR pathways synergistically cooperate to control the induction of IEGs by haloperidol. By confirming and further expanding previous observations, our results provide novel insights into the regulatory mechanisms underlying the molecular/cellular action of antipsychotics in the striatum. Copy rights belong to original authors. Visit the link for more info Podcast created by PaperPlayer

COR2ED Medical Education
ASBMR 2022 Rare Bone Disease Highlights: Episode 1

COR2ED Medical Education

Play Episode Listen Later Sep 12, 2022 16:37


In this first episode of a three-episode podcast series, COR2ED and ASBMR have partnered with Professor Anna Teti (University of L’Aquila) to provide rare bone disease highlights from the Rare Diseases Symposium that preceded the ASBMR 2022 Annual Meeting. Opening with an overview of ongoing clinical research in several rare bone diseases, Prof. Teti highlights the importance of preparing clinicians for unexpected adverse events. Notably, therapies used in the context of rare bone diseases can cause adverse events not seen if a common bone disease was treated. For osteogenesis imperfecta, she discusses a novel treatment based on umbilical cord mesenchymal stem cells. A safety study in 18 paediatric patients – three of whom received a pre-natal injection – is awaiting completion by the end of 2023. Initial safety data suggests that multiple stem cell transplantations in children with this disease is safe. Prof. Teti emphasizes the impact of achondroplasia, the most common rare bone disease, and one for which new treatments are also in development. Pharmacological treatment aims to reduce activity of the pathogenic, overactive variant of FGFR3 which causes the disease. She is confident that a treatment will be found that, at minimum, enhances quality of life in patients. Prof. Teti concludes with a review of the highly collaborative spirit of the Rare Diseases Symposium, emphasizing that patient well-being must be the driving force of research.

PaperPlayer biorxiv neuroscience
MyD88-TLR4-dependent choroid plexus activation precedes perilesional inflammation and edema in intracerebral hemorrhage

PaperPlayer biorxiv neuroscience

Play Episode Listen Later Sep 6, 2022


Link to bioRxiv paper: http://biorxiv.org/cgi/content/short/2022.09.06.506660v1?rss=1 Authors: Akeret, K., Buzzi, R. M., Thomson, B. R., Schwendinger, N., Klohs, J., Schulthess, N., Baselgia, L., Hansen, K., Regli, L., Vallelian, F., Hugelshofer, M., Schaer, D. Abstract: The functional neurological outcome of patients with intracerebral hemorrhage (ICH) strongly relates to the degree of secondary brain injury (ICH SBI) evolving within days after the initial bleeding. Different mechanisms including the incitement of inflammatory pathways, dysfunction of the blood brain barrier (BBB), activation of resident microglia, and an influx of blood-borne immune cells, have been hypothesized to contribute to ICH SBI. Yet, the spatiotemporal interplay of specific inflammatory processes within different brain compartments has not been sufficiently characterized, limiting potential therapeutic interventions to prevent and treat ICH SBI. Using a whole-blood injection model in mice, we systematically characterized the spatial and temporal dynamics of inflammatory processes after ICH using 7 Tesla magnetic resonance imaging (MRI), spatial RNA sequencing (spRNAseq), functional BBB assessment, and immunofluorescence average intensity mapping. We identified a pronounced early response of the choroid plexus (CP) peaking at 12 to 24h, that was characterized by inflammatory cytokine expression, epithelial and endothelial expression of leukocyte adhesion molecules, and the accumulation of leukocytes. In contrast, we observed a delayed secondary reaction pattern at the injection site (striatum) peaking at 96h, defined by gene expression corresponding to perilesional leukocyte infiltration and correlating to the delayed signal alteration seen on MRI. Pathway analysis revealed a dependence of the early inflammatory reaction in the CP on toll-like receptor 4 (TLR4) signaling via myeloid differentiation factor 88 (MyD88). TLR4 and MyD88 knockout mice corroborated this observation, lacking the early upregulation of adhesion molecules and leukocyte infiltration within the CP 24h after whole-blood injection. In conclusion, we report a biphasic brain reaction pattern after ICH with a MyD88 TLR4 dependent early inflammatory response of the CP, preceding inflammation, edema and leukocyte infiltration at the lesion site. Pharmacological targeting of the early CP activation might harbor the potential to modulate the development of ICH SBI. Copy rights belong to original authors. Visit the link for more info Podcast created by PaperPlayer

PaperPlayer biorxiv neuroscience
TRPA1 analgesia is mediated by kappa opioid receptors

PaperPlayer biorxiv neuroscience

Play Episode Listen Later Sep 3, 2022


Link to bioRxiv paper: http://biorxiv.org/cgi/content/short/2022.09.01.506151v1?rss=1 Authors: Semizoglou, E., Gentry, C., Vastani, N., Stucky, C. L., Andersson, D. A., Bevan, S. Abstract: TRPA1 expressed in peripheral sensory neurons is important for nociception. Pharmacological inhibition or genetic ablation of TRPA1 profoundly reduces normal behavioural sensitivity to noxious cold and mechanical stimulation, as well as sensory neuron responses to mechanical stimulation. TRPA1 inhibition also reverses cold and mechanical hypersensitivities in chronic pain models in vivo. Here we demonstrate that these striking effects of TRPA1 inactivation result from an increased constitutive activity of kappa opioid receptors (KOR) co-expressed with TRPA1 in sensory neurons. Inhibition of KOR in Trpa1-/- mice restores nociception and neuronal activity to the levels observed in wild-type mice and reverses the analgesic effects of TRPA1 antagonism in naive mice and in neuropathic and inflammatory pain conditions. TRPA1 regulation of KOR activity in sensory neurons provides a novel mechanism to produce peripherally mediated analgesia. Our findings suggest that TRP channel regulation of constitutive GPCR activity, may be a process of general physiological importance. Copy rights belong to original authors. Visit the link for more info Podcast created by PaperPlayer

PaperPlayer biorxiv neuroscience
The calcineurin regulator Sarah enables acute and chronic forms of homeostatic plasticity at the Drosophila neuromuscular junction

PaperPlayer biorxiv neuroscience

Play Episode Listen Later Sep 1, 2022


Link to bioRxiv paper: http://biorxiv.org/cgi/content/short/2022.08.31.506100v1?rss=1 Authors: Armstrong, N. S., Frank, C. A. Abstract: The ability of synapses to maintain physiological levels of evoked neurotransmission is essential for neuronal stability. A variety of perturbations can disrupt neurotransmission, but synapses often compensate for disruptions and work to stabilize activity levels, using forms of homeostatic synaptic plasticity. Presynaptic homeostatic potentiation (PHP) is one such mechanism that is expressed at the model Drosophila melanogaster larval neuromuscular junction (NMJ) synapse. In PHP, neurotransmitter release increases in response to challenges to the synapse, resulting in the maintenance of evoked neurotransmission. Prior work separated PHP into two temporal phases, acute and chronic. Those data suggested that cytoplasmic calcium signaling was important for a long-term maintenance of PHP. Here we used a combination of transgenic Drosophila RNA interference and overexpression lines, along with NMJ electrophysiology, synapse imaging, and pharmacology to test if regulators of the calcium/calmodulin-dependent protein phosphatase calcineurin are necessary for the normal expression of acute or chronic forms of PHP. We found that either pre- or postsynaptic dysregulation of a Drosophila gene regulating calcineurin, sarah (sra), blocks PHP. Examination of tissue-specific data showed that increases and decreases in sra expression are both detrimental to PHP. Additionally, the acute and chronic phases of PHP are functionally separable depending entirely upon which sra genetic manipulation is used. Surprisingly, concurrent pre- and postsynaptic sra knockdown or overexpression ameliorated PHP blocks revealed in single tissue experiments. Pharmacological inhibition of calcineurin corroborated this latter finding. Our results suggest that a discrete balance of calcineurin signaling is needed across multiple synapse tissue types and over different temporal phases to stabilize peripheral synaptic outputs. Copy rights belong to original authors. Visit the link for more info Podcast created by PaperPlayer

PaperPlayer biorxiv neuroscience
Probabilistic axon targeting dynamics lead to individualized brain wiring

PaperPlayer biorxiv neuroscience

Play Episode Listen Later Aug 26, 2022


Link to bioRxiv paper: http://biorxiv.org/cgi/content/short/2022.08.26.505432v1?rss=1 Authors: Andriatsilavo, M., Dumoulin, A., Dutta, S., Stoeckli, E. T., Hiesinger, P. R., Hassan, B. A. Abstract: Developmental variation in brain-wiring contributes to behavioural individuality1,2. However, how and when individualized wiring diagrams emerge and become stable during development remains largely unknown. Here, we explored axon targeting dynamics in individual brains using live-imaging of a developing Drosophila visual circuit and discovered that targeting choice is an algorithmic multi-step growth process with variable outcomes. Using optogenetics, we found that temporally restricted Notch lateral-inhibition defines a subset of neurons with a probabilistic potential to innervate distal targets. Next, axons from NotchOFF neurons amplify into long actin-rich multi-fibre structures necessary for distal growth. A subset of these NotchOFF neurons create distal targeting axons by stabilizing microtubule growth in one of their actin fibres. Amplified axons without tubulin-stabilized fibres retract, resulting in the stochastic selection of a different number of distal targeting axons in each brain. Pharmacological microtubule destabilization suffices to inhibit this targeting. We observed a similar axonal amplification-stabilization process in the developing chick spinal cord, suggesting a conserved mechanism. Finally, early microtubule patterns predict the adult brain- wiring of an individual in a target-independent manner prior to synapse formation3,4. Thus, we show that a temporal succession of genetically encoded stochastic processes explains the emergence of individual wiring variation. Copy rights belong to original authors. Visit the link for more info Podcast created by PaperPlayer

The Podcast by KevinMD
Non-judgmental empathy in the exam room

The Podcast by KevinMD

Play Episode Listen Later Aug 21, 2022 13:47


"I think we all have an inclination—at least from time to time—to judge others. No matter how experienced, compassionate, and professional we are as physicians, we're still human. I can admit that I have indeed struggled with patients like the 65-year-old morbidly obese male who complains at every visit about how hard it is to control his blood sugar levels with the medications prescribed. I want to convince him so badly about diet and exercise, but I have tried, and often, these patients don't want to hear it. Pharmacological or surgical interventions are the preferred route for many. I know I cannot magically change a patient's attitudes about their health. Nevertheless, I still believe that the best I can do for my patients is to offer them my sincere professional advice without prejudice or discrimination. If my physical presence is intimidating to some, I won't begrudge them for seeking a doctor who makes them feel more comfortable. In the end, I still believe that leading by example is essential for a physician and that I can use my personal experience to inspire positive change. After all, I am here to help." Francisco M. Torres is an interventional physiatrist specializing in diagnosing and treating patients with spine-related pain syndromes. He is certified by the American Board of Physical Medicine and Rehabilitation and the American Board of Pain Medicine and can be reached at Florida Spine Institute and Wellness. He shares his story and discusses his KevinMD article, "The importance of non-judgmental empathy." Did you enjoy today's episode? Rate and review the show so more audiences can find The Podcast by KevinMD. Subscribe on your favorite podcast app to get notified when a new episode comes out. Click here to earn 1.0 AMA PRA Category 1 CME for this episode. Also available in Category 1 CME bundles. Powered by CMEfy - a seamless way for busy clinician learners to discover Internet Point-of-Care Learning opportunities that reward AMA PRA Category 1 Credit(s)™. Learn more at about.cmefy.com/cme-info

Gangly Flamingo
AF News, Aug 15, 2022 | Episode 9

Gangly Flamingo

Play Episode Listen Later Aug 16, 2022 21:14


Gangly Flamingo is a podcast for the alcohol-free community about pushing through the awkwardness of rediscovering ourselves without booze. Visit www.GanglyFlamingo.com for more information and ways to connect. In this episode, creator and host, Mark Schulz, introduces a third episode type for the show: a 15-20 minute news program format covering recent events and research findings relates to Alcohol Use Disorder (AUD) and/or anxiety. This episode format will join the guest interviews and the guided meditation formats already available. Reach out and share your feedback! Episode References Cheong, JeeWon, and Jalie A. Tucker. “Utility of Interactive Voice Response Self-Monitoring in Stabilizing Initial Change during Natural Recovery Attempts among Persons with Alcohol Use Disorder.” Journal of Substance Abuse Treatment, vol. 140, Sept. 2022, p. 108831. EBSCOhost, https://doi.org/10.1016/j.jsat.2022.108831. Wilens, Timothy E., et al. “The Impact of Pharmacotherapy of Childhood-Onset Psychiatric Disorders on the Development of Substance Use Disorders.” Journal of Child and Adolescent Psychopharmacology, vol. 32, no. 4, May 2022, pp. 200–14. EBSCOhost, https://doi.org/10.1089/cap.2022.0016. Krewson, Celest. “Pharmacological treatments found effective against substance use disorders.” Contemporary Pediatrics, August 10, 2022. https://www.contemporarypediatrics.com/view/pharmacological-treatments-found-effective-against-substance-use-disorders Jaasma, Michael. (2019 May 20 - 2020 March 26). Pilot Evaluation of the Empower Neuromodulation System in AUD Patients. Identifier NCT03983317. https://clinicaltrials.gov/ct2/show/study/NCT03983317 Empower Neuromodulation System, a home-use device for the treatment of anxiety disorders. https://www.sbir.gov/node/2189423 Enjoying Gangly Flamingo? Help us spread the word! Share on Twitter Share on Facebook To stay up to date on all things Gangly, subscriber to the weekly newsletter. No materials produced by Gangly Flamingo should be treated as professional medical advice. See full legal disclaimers here --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app --- Send in a voice message: https://anchor.fm/gangly-flamingo/message Support this podcast: https://anchor.fm/gangly-flamingo/support

The Parkinson's Podcast
Urinary Dysfunction and Parkinson's

The Parkinson's Podcast

Play Episode Listen Later Aug 16, 2022 37:35


In this episode, Dr. Arun Mathur, a urologist with specialized knowledge of Parkinson's, discusses: The differences in urinary dysfunction between different neurologic diseases An explanation of urinary dysfunction Urinary dysfunction as a potential precursor to Parkinson's Urinary dysfunction's impact on quality of life When you should seek treatment When urinary dysfunction occurs Non-pharmacological and surgical treatments DBS and urinary dysfunction Carbidopa/levodopa's effect on urinary dysfunction Pharmacological treatments Catheterization Prostate symptoms versus Parkinson's symptoms For a video recording, related resources and more visit: http://davisphinneyfoundation.org/podcast-recording-urinary-dysfunction-and-parkinsons

Cocoa Pods
Part 3: Obesity-the role of stigma; Obesity medications

Cocoa Pods

Play Episode Listen Later Aug 11, 2022 33:05


Dr Tiffany Powell-Wiley's obesity talk Part 3: Obesity Timestamps (01:15) Challenge of obesity in society (06:44) Managing stigmas (10:25) Causes of obesity (13:15) Changes in energy storage (16:07) Prevalence of Chronic conditions (18:25) Pharmacological drugs to lose weight? (20:12) Laws to combat obesity? (21:43) Future of the obesity epidemic (23:13) Obesity and covid (25:37) Are we committed to improving obesity? (29:07) Affordability of treatment (32:20) Closing remarks Dr. Tiffany Powell-Wiley is here again to continue the discussion of obesity and its many accompanying factors. Today, Dr. Bola Sogade and Dr. Tiffany Powell-Wiley highlight the stigma surrounding obesity. This stigma creates additional challenges for obese individuals in our society. Dr. Powell-Wiley emphasizes the need for stigma education for health professionals in order to improve health outcomes. In this episode, the two doctors also discuss treatment and intervention for obesity. With new possibilities for treatment, Dr. Powell-Wiley sees hope in improving the obesity epidemic. By acknowledging the complexity of obesity and addressing it in various ways, we can help make healthy choices the easy choices. #obesity #obesitystigma #obesityepidemic #obgyn #womenshealth #obesityrisks #healthandwellness

Health Longevity Secrets
Bradley S Rosen MD: Rapamycin and Acarbose for Longevity in Practice

Health Longevity Secrets

Play Episode Listen Later Aug 9, 2022 47:27 Transcription Available


Pharmacological approaches to longevity using drugs like rapamycin and Acarbose via targeting signaling molecules like mTOR and insulin continue to see growing support. Today we speak with Bradley S Rosen MD whose practice focuses on Living Healthier and Longer through Biogerontology. Dr Rosen graduated with a degree in Mathematics and Statistics and an MD from the University of Florida. His residency was at Jules Stein Eye Institute at UCLA, followed by 2 Retina Fellowships at the Lions Eye Institute and the Royal Victorian Eye and Ear Hospital in Melbourne, Australia. In 2013 Dr. Rosen, M.D. joined a growing number of scientists and clinicians who are becoming increasingly interested in the fact that the hallmarks of aging themselves can and should be targeted for therapy.https://mtormd.com/ @DrBradleyRosen1Lu, Yuancheng, Benedikt Brommer, Xiao Tian, Anitha Krishnan, Margarita Meer, Chen Wang, Daniel L. Vera, et al. “Reprogramming to Recover Youthful Epigenetic Information and Restore Vision.” Nature 588, no. 7836 (December 3, 2020): 124–29. https://doi.org/10.1038/s41586-020-2975-4.Jiang, Zhou, Juan Wang, Denise Imai, Tim Snider, Jenna Klug, Ruby Mangalindan, John Morton, et al. “Short Term Treatment with a Cocktail of Rapamycin, Acarbose and Phenylbutyrate Delays Aging Phenotypes in Mice.” Scientific Reports 12, no. 1 (December 2022): 7300. https://doi.org/10.1038/s41598-022-11229-1.https://www.nature.com/articles/s41598-022-11229-1 *** CONNECT WITH ROBERT LUFKIN MD ON SOCIAL MEDIA ***Web: https://robertlufkinmd.com/ Twitter:https://twitter.com/robertlufkinmdYoutube: https://www.youtube.com/RobertLufkinMD*** MEMBERSHIP ***https://robert-lufkin.mykajabi.com/membership *** SPONSORSHIPS & BRANDS ***We do work with sponsors and brands. If you are interested in working with us for your health industry product or service, please contact us at: https://robertlufkinmd.com/contact  NOTE: This is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have. Never disregard professional medical advice or delay in seeking it because of something you have seen here. Robert Lufkin MD may at any time and at its sole discretion change or replace the information available on this channel. To the extent permitted by mandatory law, Robert Lufkin MD shall not be liable for any direct, incidental, consequential, indirect or punitive damages arising out of access to or use of any content available on this channel, including viruses, regardless of the accuracy or completeness of any such content.Disclaimer: We are ambassadors or affiliates for many of the brands we reference on the channel.Support the show

Bite-Sized Medicine

In this episode we cover green tea, discussing whether the evidence points to any truth behind its purported health benefits. Highlights include studies on green tea and blood pressure, inflammation, cancer mortality, and more. Enjoy! References: Xu, R., Yang, K., Ding, J., & Chen, G. (2020). Effect of green tea supplementation on blood pressure: A systematic review and meta-analysis of randomized controlled trials. Medicine, 99(6), e19047. https://doi.org/10.1097/MD.0000000000019047 Xu, R., Yang, K., Li, S., Dai, M., & Chen, G. (2020). Effect of green tea consumption on blood lipids: a systematic review and meta-analysis of randomized controlled trials. Nutrition journal, 19(1), 48. https://doi.org/10.1186/s12937-020-00557-5 Lin, Y., Shi, D., Su, B., Wei, J., Găman, M. A., Sedanur Macit, M., Borges do Nascimento, I. J., & Guimaraes, N. S. (2020). The effect of green tea supplementation on obesity: A systematic review and dose-response meta-analysis of randomized controlled trials. Phytotherapy research : PTR, 34(10), 2459–2470. https://doi.org/10.1002/ptr.6697 Asbaghi, O., Fouladvand, F., Gonzalez, M. J., Aghamohammadi, V., Choghakhori, R., & Abbasnezhad, A. (2021). Effect of Green Tea on Anthropometric Indices and Body Composition in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Effekt von grünem Tee auf anthropometrische Indizes und die Körperzusammensetzung bei Patienten mit Diabetes mellitus Typ 2: eine systematische Übersicht und Metaanalyse. Complementary medicine research, 28(3), 244–251. https://doi.org/10.1159/000511665 Asbaghi, O., Fouladvand, F., Gonzalez, M. J., Ashtary-Larky, D., Choghakhori, R., & Abbasnezhad, A. (2021). Effect of green tea on glycemic control in patients with type 2 diabetes mellitus: A systematic review and meta-analysis. Diabetes & metabolic syndrome, 15(1), 23–31. https://doi.org/10.1016/j.dsx.2020.11.004 Haghighatdoost, F., & Hariri, M. (2019). The effect of green tea on inflammatory mediators: A systematic review and meta-analysis of randomized clinical trials. Phytotherapy research : PTR, 33(9), 2274–2287. https://doi.org/10.1002/ptr.6432 Filippini, T., Malavolti, M., Borrelli, F., Izzo, A. A., Fairweather-Tait, S. J., Horneber, M., & Vinceti, M. (2020). Green tea (Camellia sinensis) for the prevention of cancer. The Cochrane database of systematic reviews, 3(3), CD005004. https://doi.org/10.1002/14651858.CD005004.pub3 Yu, S., Zhu, L., Wang, K., Yan, Y., He, J., & Ren, Y. (2019). Green tea consumption and risk of breast cancer: A systematic review and updated meta-analysis of case-control studies. Medicine, 98(27), e16147. https://doi.org/10.1097/MD.0000000000016147 Zhao, H., Mei, K., Yang, L., Liu, X., & Xie, L. (2021). Green tea consumption and risk for esophageal cancer: A systematic review and dose-response meta-analysis. Nutrition (Burbank, Los Angeles County, Calif.), 87-88, 111197. https://doi.org/10.1016/j.nut.2021.111197 Awortwe, C., Bruckmueller, H., & Cascorbi, I. (2019). Interaction of herbal products with prescribed medications: A systematic review and meta-analysis. Pharmacological research, 141, 397–408. https://doi.org/10.1016/j.phrs.2019.01.028 Supported by the Innovation Studio at the Ohio State University

Real World NP
Treating Patients With Insomnia

Real World NP

Play Episode Listen Later Jul 12, 2022 18:10 Very Popular


By the time the patient with insomnia makes it to primary care, they have probably been struggling with sleep for a while, and have probably tried some things on their own – without luck. And now they're hoping YOU can fix it, preferably…tonight?Insomnia is a murky clinical topic; it's not always as simple as not getting enough sleep. If you aren't sure where to start with the patient with insomnia, let's get you sure. This week, we'll talk about:✅ Sleep hygiene – what it is and why it's important in patients with insomnia✅ The role of substances (alcohol, caffeine, nicotine) in sleep issues✅ Getting an insomnia/sleep history✅ Comorbidities that can be causing or contributing to their insomnia✅ Pharmacological approach to treating insomnia✅ Non-pharmacological approach to treating insomniaThere aren't any tests or labs for diagnosing insomnia. Digging deep and getting a very good history is the biggest part of understanding what is going on and developing the best plan to get your patient the relief they need. -----------------------Don't forget to grab your free Ultimate Resource Guide for the New NP at https://www.realworldnp.com/guideSign up for the Lab Interpretation Crash Course: https://www.realworldnp.com/labs Grab your copy of the Digital NP Binder: https://www.realworldnp.com/binder------------------------Come follow along for even more tips and inspiration:Instagram: https://instagram.com/realworldnpFacebook: https://facebook.com/realworldnp_______________________________© 2022 Real World NP. For educational and informational purposes only, see realworldnp.com/disclaimer for full details. See acast.com/privacy for privacy and opt-out information.

Dementia Matters
Non-Pharmacological Care for People with MCI and Dementia: Plenary Preview with Dr. Linda Lam

Dementia Matters

Play Episode Listen Later Jul 12, 2022 17:57


AAIC Special Series Part 3: Mild cognitive impairment (MCI) is an early stage of memory loss and cognitive impairment that can develop into dementia. While physicians have medications they can prescribe to manage the condition, many researchers and doctors are focusing on lifestyle interventions that could support a person's cognition and address behavioral changes. Dr. Linda Lam joins the podcast to discuss her work studying mild cognitive impairment and preview her upcoming AAIC plenary talk on non-pharmacological treatments for MCI and dementia. Guest: Linda Lam, MBChB, MD, professor, Chinese University of Hong Kong Show Notes AAIC is the world's largest forum for the dementia research community. Register for the plenary events, which are free to the public with registration, at the AAIC website. Learn more about Dr. Linda Lam on the Chinese University of Hong Kong website. Connect with us Find transcripts and more at our website. Email Dementia Matters: dementiamatters@medicine.wisc.edu Follow us on Facebook and Twitter. Subscribe to the Wisconsin Alzheimer's Disease Research Center's e-newsletter.

Hypertrophic Cardiomyopathy Podcast Series
HCM and New Pharmacological Agents

Hypertrophic Cardiomyopathy Podcast Series

Play Episode Listen Later Jun 27, 2022 37:39


Making the correct of hypertrophic cardiomyopathy (HCM) is critical in being able to initiate early surveillance and therapy to improve patient outcomes.  In this podcast focusing on pharmacologic treatment options, learn more about completed and ongoing myosin inhibitor clinical trials.

The Gary Null Show
The Gary Null Show - 06.13.22

The Gary Null Show

Play Episode Listen Later Jun 13, 2022 57:20 Very Popular


Videos: 1. Water Crisis Clip – 19:05* ‘Five-alarm fire': Arizona water crisis accelerates with tough choices ahead – The Arizona Republic's Joanna Allhands * Sacrificing Lake Mead to Save Lake Powell – timeBomb * Lake Mead Is Almost Empty – The Other Me * 40 Million People Rely on the Colorado River, and Now It's Drying Up – Vice * The Town Trying to Pump Billions of Gallons of Water to Their Desert Community – Vice 2. Assange Countdown: In Depth with Dr. George Szamuely (0:20) 3. NBC News just SMEARED real journalists in shameful hit piece | Redacted with Clayton Morris (22:00) 4. Propaganda disguised as education | Let's talk about it – Riks (Start @ 0:58) 5. A Christian Response to Wokeness (FULL VIDEO) | Noelle Mering | Leadership Institute 6. Woody Allen speech from movie The Front   Olive oil nutrient may help prevent brain cancer Wellcome Trust Centre for Cell Biology, June 10, 2022 A compound found in olive oil may help to prevent cancer developing in the brain, a study shows.Research into oleic acid – the primary ingredient in olive oil – has shown how it can help prevent cancer-causing genes from functioning in cells.The oily substance – one of a group of nutrients known as fatty acids – stimulates the production of a cell molecule whose function is to prevent cancer-causing proteins from forming.Scientists from the University analysed the effect of oleic acid on a cell molecule, known as miR-7, which is active in the brain and is known to suppress the formation of tumours. They found that oleic acid prevents a cell protein, known as MSI2, from stopping production of miR-7. In this way, the olive oil component supports the production of miR-7, which helps prevent tumours from forming.Researchers made their discoveries in tests on human cell extracts and in living cells in the lab. CDC lists oil of lemon eucalyptus as comparable to DEET for mosquitoes CDC, June 9, 2022 Even the CDC recommends this botanical ingredient as comparable to DEET for repelling disease-carrying insects. While DEET is the gold standard of insect repellents, it is also a strong synthetic chemical with a tarnished reputation. Known to the chemistry set as N,N-Diethyl-meta-toluamide, DEET was potentially linked to cases of brain damage in the 1980s and 90s, inciting a flood of fear amongst consumers that has yet to recede. BUT, there's an alternative. Behold oil of lemon eucalyptus (OLE), the plant-based active ingredient derived from eucalyptus leaves and approved for efficacy by the CDC. “Oil of lemon eucalyptus (OLE) or PMD (chemical name: para-menthane-3,8-diol), the synthesized version of OLE. Products containing OLE and PMD include, but are not limited to, Repel and Off! Botanicals. This recommendation refers to EPA-registered products containing the active ingredient OLE (or PMD). “Pure” oil of lemon eucalyptus (essential oil not formulated as a repellent) is not recommended; it has not undergone similar, validated testing for safety and efficacy and is not registered with EPA as an insect repellent.” Just 5 Minutes Of Breath Training Every Day Makes Exercise Easier For Adults University of Colorado, June 11, 2022 A handheld device which builds breathing muscles could help older people get in shape. Doing just five minutes of the breath training exercises every day for more than six weeks improved people's performance on the treadmill by 12 percent, according to scientists. Adults are recommended to log 150 minutes of moderate exercise a week. Now scientists have come up with a simple way of making exercising on the treadmill easier for those struggling to get running. “Developing novel forms of physical training that increase adherence and improve physical function are key to reducing the risk of chronic diseases with aging,” says lead researcher Kaitlin Freeberg, of the University of Colorado, in a statement. “High-resistance IMST (high-resistance inspiratory muscle strength training) may be one such strategy to promote adherence and improve multiple components of health in midlife and older adults.” IMST involves inhaling through a handheld device which adds resistance to the breath. A total of 35 adults were divided into two groups, a high resistance training group and a low resistance control group. Participants used a manual breathing trainer for 30 breaths a day, or around five minutes, over a period of six weeks. Those who were part of the high-resistance group improved their treadmill time by 12 percent, the researchers report. Participants in the high-resistance group also showed a relationship with changes in 18 metabolites tested in the study, “predominantly ones that play key roles in energy production and fatty acid metabolism.” Pregnant women produce super antibodies to protect newborns, now scientists know how Cincinnati Children's Hospital Medical Center, June 8, 2022 Scientists discovered years ago that newborn infants depend upon immune components transferred from their mothers to survive the onslaught of pathogens that begin invading their bodies as soon as they are born.  Now, a far-reaching study published in Nature, provides a surprising explanation of how those early days of mother-provided immunity actually work–and what that information could mean for preventing death and disability from a wide range of infectious diseases.  “For many years, scientists believed that antibodies cannot get inside cells. They don't have the necessary machinery. And so, infections caused by pathogens that live exclusively inside cells were thought to be invisible to antibody-based therapies,” says Sing Sing Way, MD, Ph.D., Division of Infectious Diseases at Cincinnati Children's. “Our findings show that pregnancy changes the structure of certain sugars attached to the antibodies, which allows them to protect babies from infection by a much wider range of pathogens.”  “The maternal-infant dyad is so special. It's the intimate connection between a mother and her baby,” says John Erickson, MD, Ph.D., Division of Neonatology, and first-author of the study. Erickson continues, “This special connection starts when babies are in the womb and continues after birth. I love seeing the closeness between mothers and their babies in our newborn care units. This discovery paves the way for pioneering new therapies that can specifically target infections in pregnant mothers and newborns babies. I believe these findings also will have far-reaching implications for antibody-based therapies in other fields.” Fasting boosts stem cells' regenerative capacity Massachusetts Institute of Technology, June 3, 2022  As people age, their intestinal stem cells begin to lose their ability to regenerate. These stem cells are the source for all new intestinal cells, so this decline can make it more difficult to recover from gastrointestinal infections or other conditions that affect the intestine. This age-related loss of stem cell function can be reversed by a 24-hour fast, according to a new study from MIT biologists. The researchers found that fasting dramatically improves stem cells' ability to regenerate, in both aged and young mice. In fasting mice, cells begin breaking down fatty acids instead of glucose, a change that stimulates the stem cells to become more regenerative. The researchers found that they could also boost regeneration with a molecule that activates the same metabolic switch. Such an intervention could potentially help older people recovering from GI infections or cancer patients undergoing chemotherapy, the researchers say. “This study provided evidence that fasting induces a metabolic switch in the intestinal stem cells, from utilizing carbohydrates to burning fat,” Sabatini says. “Interestingly, switching these cells to fatty acid oxidation enhanced their function significantly. Pharmacological targeting of this pathway may provide a therapeutic opportunity to improve tissue homeostasis in age-associated pathologies.” After mice fasted for 24 hours, the researchers removed intestinal stem cells and grew them in a culture dish, allowing them to determine whether the cells can give rise to “mini-intestines” known as organoids. The researchers found that stem cells from the fasting mice doubled their regenerative capacity.

New Books in History
Andrew Bickford, "Chemical Heroes: Pharmacological Supersoldiers in the US Military" (Duke UP, 2021)

New Books in History

Play Episode Listen Later Jun 3, 2022 62:35


In Chemical Heroes: Pharmacological Supersoldiers in the US Military (Duke UP, 2021), Andrew Bickford analyzes the US military's attempts to design performance enhancement technologies and create pharmacological "supersoldiers" capable of withstanding extreme trauma. Bickford traces the deep history of efforts to biologically fortify and extend the health and lethal power of soldiers from the Cold War era into the twenty-first century, from early adoptions of mandatory immunizations to bio-protective gear, to the development and spread of new performance enhancing drugs during the global War on Terrorism. In his examination of government efforts to alter soldiers' bodies through new technologies, Bickford invites us to contemplate what constitutes heroism when armor becomes built in, wired in, and even edited into the molecular being of an American soldier. Lurking in the background and dark recesses of all US military enhancement research, Bickford demonstrates, is the desire to preserve US military and imperial power. Dr. Bickford is Associate Professor of Anthropology at Georgetown University. You can learn more about his work here.  Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/history

New Books in Military History
Andrew Bickford, "Chemical Heroes: Pharmacological Supersoldiers in the US Military" (Duke UP, 2021)

New Books in Military History

Play Episode Listen Later Jun 3, 2022 62:35


In Chemical Heroes: Pharmacological Supersoldiers in the US Military (Duke UP, 2021), Andrew Bickford analyzes the US military's attempts to design performance enhancement technologies and create pharmacological "supersoldiers" capable of withstanding extreme trauma. Bickford traces the deep history of efforts to biologically fortify and extend the health and lethal power of soldiers from the Cold War era into the twenty-first century, from early adoptions of mandatory immunizations to bio-protective gear, to the development and spread of new performance enhancing drugs during the global War on Terrorism. In his examination of government efforts to alter soldiers' bodies through new technologies, Bickford invites us to contemplate what constitutes heroism when armor becomes built in, wired in, and even edited into the molecular being of an American soldier. Lurking in the background and dark recesses of all US military enhancement research, Bickford demonstrates, is the desire to preserve US military and imperial power. Dr. Bickford is Associate Professor of Anthropology at Georgetown University. You can learn more about his work here.  Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/military-history

New Books in Science, Technology, and Society
Andrew Bickford, "Chemical Heroes: Pharmacological Supersoldiers in the US Military" (Duke UP, 2021)

New Books in Science, Technology, and Society

Play Episode Listen Later Jun 3, 2022 62:35


In Chemical Heroes: Pharmacological Supersoldiers in the US Military (Duke UP, 2021), Andrew Bickford analyzes the US military's attempts to design performance enhancement technologies and create pharmacological "supersoldiers" capable of withstanding extreme trauma. Bickford traces the deep history of efforts to biologically fortify and extend the health and lethal power of soldiers from the Cold War era into the twenty-first century, from early adoptions of mandatory immunizations to bio-protective gear, to the development and spread of new performance enhancing drugs during the global War on Terrorism. In his examination of government efforts to alter soldiers' bodies through new technologies, Bickford invites us to contemplate what constitutes heroism when armor becomes built in, wired in, and even edited into the molecular being of an American soldier. Lurking in the background and dark recesses of all US military enhancement research, Bickford demonstrates, is the desire to preserve US military and imperial power. Dr. Bickford is Associate Professor of Anthropology at Georgetown University. You can learn more about his work here.  Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/science-technology-and-society

New Books in Drugs, Addiction and Recovery
Andrew Bickford, "Chemical Heroes: Pharmacological Supersoldiers in the US Military" (Duke UP, 2021)

New Books in Drugs, Addiction and Recovery

Play Episode Listen Later Jun 3, 2022 62:35


In Chemical Heroes: Pharmacological Supersoldiers in the US Military (Duke UP, 2021), Andrew Bickford analyzes the US military's attempts to design performance enhancement technologies and create pharmacological "supersoldiers" capable of withstanding extreme trauma. Bickford traces the deep history of efforts to biologically fortify and extend the health and lethal power of soldiers from the Cold War era into the twenty-first century, from early adoptions of mandatory immunizations to bio-protective gear, to the development and spread of new performance enhancing drugs during the global War on Terrorism. In his examination of government efforts to alter soldiers' bodies through new technologies, Bickford invites us to contemplate what constitutes heroism when armor becomes built in, wired in, and even edited into the molecular being of an American soldier. Lurking in the background and dark recesses of all US military enhancement research, Bickford demonstrates, is the desire to preserve US military and imperial power. Dr. Bickford is Associate Professor of Anthropology at Georgetown University. You can learn more about his work here.  Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/drugs-addiction-and-recovery

New Books in American Studies
Andrew Bickford, "Chemical Heroes: Pharmacological Supersoldiers in the US Military" (Duke UP, 2021)

New Books in American Studies

Play Episode Listen Later Jun 3, 2022 62:35


In Chemical Heroes: Pharmacological Supersoldiers in the US Military (Duke UP, 2021), Andrew Bickford analyzes the US military's attempts to design performance enhancement technologies and create pharmacological "supersoldiers" capable of withstanding extreme trauma. Bickford traces the deep history of efforts to biologically fortify and extend the health and lethal power of soldiers from the Cold War era into the twenty-first century, from early adoptions of mandatory immunizations to bio-protective gear, to the development and spread of new performance enhancing drugs during the global War on Terrorism. In his examination of government efforts to alter soldiers' bodies through new technologies, Bickford invites us to contemplate what constitutes heroism when armor becomes built in, wired in, and even edited into the molecular being of an American soldier. Lurking in the background and dark recesses of all US military enhancement research, Bickford demonstrates, is the desire to preserve US military and imperial power. Dr. Bickford is Associate Professor of Anthropology at Georgetown University. You can learn more about his work here.  Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/american-studies

New Books in Anthropology
Andrew Bickford, "Chemical Heroes: Pharmacological Supersoldiers in the US Military" (Duke UP, 2021)

New Books in Anthropology

Play Episode Listen Later Jun 3, 2022 62:35


In Chemical Heroes: Pharmacological Supersoldiers in the US Military (Duke UP, 2021), Andrew Bickford analyzes the US military's attempts to design performance enhancement technologies and create pharmacological "supersoldiers" capable of withstanding extreme trauma. Bickford traces the deep history of efforts to biologically fortify and extend the health and lethal power of soldiers from the Cold War era into the twenty-first century, from early adoptions of mandatory immunizations to bio-protective gear, to the development and spread of new performance enhancing drugs during the global War on Terrorism. In his examination of government efforts to alter soldiers' bodies through new technologies, Bickford invites us to contemplate what constitutes heroism when armor becomes built in, wired in, and even edited into the molecular being of an American soldier. Lurking in the background and dark recesses of all US military enhancement research, Bickford demonstrates, is the desire to preserve US military and imperial power. Dr. Bickford is Associate Professor of Anthropology at Georgetown University. You can learn more about his work here.  Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/anthropology

New Books in National Security
Andrew Bickford, "Chemical Heroes: Pharmacological Supersoldiers in the US Military" (Duke UP, 2021)

New Books in National Security

Play Episode Listen Later Jun 3, 2022 62:35


In Chemical Heroes: Pharmacological Supersoldiers in the US Military (Duke UP, 2021), Andrew Bickford analyzes the US military's attempts to design performance enhancement technologies and create pharmacological "supersoldiers" capable of withstanding extreme trauma. Bickford traces the deep history of efforts to biologically fortify and extend the health and lethal power of soldiers from the Cold War era into the twenty-first century, from early adoptions of mandatory immunizations to bio-protective gear, to the development and spread of new performance enhancing drugs during the global War on Terrorism. In his examination of government efforts to alter soldiers' bodies through new technologies, Bickford invites us to contemplate what constitutes heroism when armor becomes built in, wired in, and even edited into the molecular being of an American soldier. Lurking in the background and dark recesses of all US military enhancement research, Bickford demonstrates, is the desire to preserve US military and imperial power. Dr. Bickford is Associate Professor of Anthropology at Georgetown University. You can learn more about his work here.  Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/national-security

New Books in Medicine
Andrew Bickford, "Chemical Heroes: Pharmacological Supersoldiers in the US Military" (Duke UP, 2021)

New Books in Medicine

Play Episode Listen Later Jun 3, 2022 62:35


In Chemical Heroes: Pharmacological Supersoldiers in the US Military (Duke UP, 2021), Andrew Bickford analyzes the US military's attempts to design performance enhancement technologies and create pharmacological "supersoldiers" capable of withstanding extreme trauma. Bickford traces the deep history of efforts to biologically fortify and extend the health and lethal power of soldiers from the Cold War era into the twenty-first century, from early adoptions of mandatory immunizations to bio-protective gear, to the development and spread of new performance enhancing drugs during the global War on Terrorism. In his examination of government efforts to alter soldiers' bodies through new technologies, Bickford invites us to contemplate what constitutes heroism when armor becomes built in, wired in, and even edited into the molecular being of an American soldier. Lurking in the background and dark recesses of all US military enhancement research, Bickford demonstrates, is the desire to preserve US military and imperial power. Dr. Bickford is Associate Professor of Anthropology at Georgetown University. You can learn more about his work here.  Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/medicine

New Books Network
Andrew Bickford, "Chemical Heroes: Pharmacological Supersoldiers in the US Military" (Duke UP, 2021)

New Books Network

Play Episode Listen Later Jun 3, 2022 62:35


In Chemical Heroes: Pharmacological Supersoldiers in the US Military (Duke UP, 2021), Andrew Bickford analyzes the US military's attempts to design performance enhancement technologies and create pharmacological "supersoldiers" capable of withstanding extreme trauma. Bickford traces the deep history of efforts to biologically fortify and extend the health and lethal power of soldiers from the Cold War era into the twenty-first century, from early adoptions of mandatory immunizations to bio-protective gear, to the development and spread of new performance enhancing drugs during the global War on Terrorism. In his examination of government efforts to alter soldiers' bodies through new technologies, Bickford invites us to contemplate what constitutes heroism when armor becomes built in, wired in, and even edited into the molecular being of an American soldier. Lurking in the background and dark recesses of all US military enhancement research, Bickford demonstrates, is the desire to preserve US military and imperial power. Dr. Bickford is Associate Professor of Anthropology at Georgetown University. You can learn more about his work here.  Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

Network Five Emergency Medicine Journal Club
Episode 16 - Neurology: Part 3 - Status Epilepticus & Pharmacological Agents

Network Five Emergency Medicine Journal Club

Play Episode Listen Later May 29, 2022 29:57


Theme: Neurology. Participants: Dr Hugo Morales (neurologist), Dr James Tadros (emergency physician), Jessica Stabler (epilepsy fellow), Kim Van Vu, Mariez Gorgi and Shreyas Iyer. Discussion:Chamberlain, J., Kapur, J., Shinnar, S., Elm, J., Holsti, M., & Babcock, L. et al. (2020). Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial. The Lancet, 395(10231), 1217-1224. https://doi.org/10.1016/s0140-6736(20)30611-5. Presenter: Jessica StablerMusic/Sound Effects: Help You Out by Leonell Cassio ft. Jonathon Robins | https://soundcloud.com/leonellcassio, Music promoted by https://www.free-stock-music.com, Creative Commons Attribution-ShareAlike 3.0 Unported, https://creativecommons.org/licenses/by-sa/3.0/deed.en_US.  Nightswim by Scandinavianz | https://soundcloud.com/scandinavianz, Music promoted by https://www.free-stock-music.comCreative Commons Attribution 3.0 Unported License, https://creativecommons.org/licenses/by/3.0/deed.en_US. Ocean Love by LiQWYD | https://www.liqwydmusic.com, Music promoted by https://www.free-stock-music.com, Creative Commons Attribution 3.0 Unported License, https://creativecommons.org/licenses/by/3.0/deed.en_US. River by MusicbyAden | https://soundcloud.com/musicbyaden, Music promoted by https://www.free-stock-music.com, Creative Commons Attribution-ShareAlike 3.0 Unported, https://creativecommons.org/licenses/by-sa/3.0/deed.en_US. Slipz (audio logo) by tubebackr | https://soundcloud.com/tubebackr, Music promoted by https://www.free-stock-music.com. Sound effects from https://www.free-stock-music.com.  The Travelling Symphony by Savfk | https://www.youtube.com/savfkmusic, Music promoted by https://www.free-stock-music.comAttribution 4.0 International (CC BY 4.0), https://creativecommons.org/licenses/by/4.0/.  Thank you for listening!Please send us an email to let us know what you thought.You can contact us at westmeadedjournalclub@gmail.com.You can also follow us on Facebook, Instagram, and Twitter!See you next time!~

Cincinnati Edition
UC symposium explores non-pharmacological approaches to treating chronic pain

Cincinnati Edition

Play Episode Listen Later May 10, 2022 22:59


UC Center for Integrative Health and Wellness is hosting a symposium to explore alternative approaches to pain management.

Dentist Brain Candy
S2EP11: Milestone Contributions to Jaw Surgery

Dentist Brain Candy

Play Episode Listen Later Apr 25, 2022 11:01


On this episode of Dentist Brain Candy, I cover two thought-provoking articles from the October 2021 edition of the Journal of Oral and Maxillofacial Surgery. The first one, by Jeffrey C. Posnick, DMD, MD, discusses in depth the milestone contributions of notable surgeons and orthodontist pioneers in orthognathic surgery (OGS). This article discusses the history of innovative care solutions for treating jaw deformities and how they've led to new treatment options, including the impact of technology in dramatically reducing the barriers to treatment. I also discuss an article by Jordan S. Elmowitz, DMD  et al. that shares the findings from a study of the current pharmacological and non-pharmacological methods of postoperative pain control following oral and maxillofacial surgery. The study included surgery patients undergoing the extraction of third molars and the use and effectiveness of rescue analgesics. Listen in to learn about my treatment plan to reduce narcotic prescriptions while making my patients more comfortable. Key Takeaways How 3 dental surgeons: Hugo Obwegeser, William Bell, and Hans Luhr pioneered orthognathic surgery How orthodontists Edward Angle, William Proffit, and Lawrence Andrews changed jaw reconstruction Why only 1 in 20 of the 5% of people with a significant jaw deformity undergo surgical correction How simulation-based training is creating better jaw surgery outcomes The role of insurance-based barriers in the correction of dental-facial deformities How COX-2 inhibitors provide greater analgesic effects when compared to NSAIDs How I use Bupivacaine to reduce narcotic prescriptions while making my patients more comfortable Connect with Dr. Bryan McLelland Dentist Brain Candy Dentist Brain Candy on Facebook Dentist Brain Candy on YouTube Dentist Brain Candy Podcast Dentist Brain Candy App Dentist Brain Candy Continuing Education About Dr. Bryan McLelland Dr. Jawbreaker on YouTube Email bryanmclelland@hotmail.com Call (509) 922-2273 Resources June 10 Event Exparel Master Class Orthognathic Surgery: Past – Present – Future by Jeffrey C. Posnick, DMD, MD. in the Journal of Oral and Maxillofacial Surgery  Pharmacological and Non-Pharmacological Methods of Postoperative Pain Control Following Oral and Maxillofacial Surgery: A Scoping Review by Jordan S. Elmowitz, DMD and Raymond P. Shupak, DMD, MD, MBE in the Journal of Oral and Maxillofacial Surgery 

PT Pintcast - Physical Therapy
Collaborating to Eliminate Complications of Diabetes

PT Pintcast - Physical Therapy

Play Episode Listen Later Apr 25, 2022 42:04


Adenike Atanda is a pharmacist, director of the Diabetes Self-Management Program, and certified diabetes educator with an interest in diabetes management with a focus on insulin therapy and the effects of obesity on pharmacotherapy and disease pathophysiology.Kate Taylor is a nurse practitioner working with older adults in both outpatient and home health settings. She also is the clinical executive for SafeCare Texas, a non profit group whose goal is to eliminate preventable harm. Ken Miller is a physical therapist and assistant professor at the University of North Texas Health Science Center specializing in best practices for older adults and the home health setting to provide the highest quality of care.Teresa Wagner is a registered dietitian, expert in health literacy and certified in lifestyle medicine, public health, patient safety and health coaching, and community health worker instructor. Her research focuses on alleviating health disparities in underserved communities through her literacy to improve population health. Episode TakeawaysLearn treatment options for Type II Diabetes How to implement and educate through a Diabetes Self-Management ProgramLifestyle choices, nutrition and physical activity for the older adult with diabetesPotential outcome measures to assist the healthcare worker in identifying frailty Pharmacological and non-pharmacological options for this population Three things to never leave your providers office without knowingWhat is my main problem?What do I need to do about it?Why do I need to do it? Recommended ResourcesAmerican Diabetes Association Academy of Nutrition and DieteticsSafer Care Texas - WebLitLegit (resource for reliable and credible information) Parting Shot“My biggest message as clinicians is to leverage our strengths and to work more colalboatly with each other.” - Adenike Atanda “Make sure the instructions you provide to your patients are understandable and actionable at home.” - Teresa Wagner “ Don't not ask questions to your patients… Until you validate what they are doing, we don't know.” - Kate Taylor “Partner with our patients and partner with each other.” - Ken Miller Connect with the PanelKen: TwitterTeresa: Twitter, Instagram, WebsitePT Pintcast is brewed by:Practice Freedom UFor PT Owners who want to Treat Less, Earn More, and create the business you've always dreamed of. Take the Practice Quiz now to see where you stack up. Visit practicefreedomu.com.FYZICAL Therapy and Balance CentersDo you want to open a Physical Therapy Practice? Thinking about selling your practice?You should know this: on average, a private practice who joins the FYZICAL network grows more than 40%! If you're ready to discover how the largest network of PT private practice owners are growing and adapting to industry changes, visit FYZICALFranchise.comCBDRX4U.comYOUR CBD Store - get the ABC's of CBD at CBDRX4u.comJackson TherapyProviding awesome adventures in patient care for physical therapists who care about where they're going! Look no further than JacksonTherapy.comMW TherapyAn EMR is to a Physical Therapist as a Hammer is to a Carpenter. You deserve to LOVE USING IT!It's time for something better. It's time for something customizable. That's where MWTherapy comes in, take a demo of their amazing EMR now at MWTherapy.com where switching your EMR is easy!FIRST ROUND Owens Recovery ScienceYour single course for clinicians who want certification in Personalized Blood Flow Restriction Rehabilitation Training and the equipment YOU Need to apply it properly In your clinical practice. Find out where you can get certified NEXT at www.owensrecoveryscience.com. PARTING SHOTThe Academy of Orthopaedic Physical TherapyThe leaders in orthopedic PT are the academy OF orthopedic PT, orthoPT.org now with Current concepts of Orthopedic PT 5th edition.

Occupational Therapy Insights
Improvements in health-related quality of life and function in middle-aged women with chronic diseases of lifestyle after participating in a non-pharmacological intervention programme: A pragmatic randomised controlled trial

Occupational Therapy Insights

Play Episode Listen Later Mar 2, 2022


Musculoskeletal diseases consume a large amount of health and social resources and are a major cause of disability in both low- and high-income countries. In addition, patients frequently present with co-morbid chronic diseases of lifestyle. The area of musculoskeletal disease is restricted by a lack of epidemiological knowledge, particularly in low- and middleincome countries.

JACC Podcast
Optimal Background Pharmacological Therapy for Heart Failure Patients in Clinical Trials: JACC Review Topic of the Week

JACC Podcast

Play Episode Listen Later Jan 31, 2022 8:54


Daily cardiology
Pharmacological approach to ACS management in patients on DOAC

Daily cardiology

Play Episode Listen Later Jan 27, 2022 28:22


Challenges on fibrinolytic therapy and primary PCI issues in admitted ACS patients on DOACs

Emergency Medical Minute
Podcast 747: Food Impaction

Emergency Medical Minute

Play Episode Listen Later Jan 17, 2022 3:08


Contributor: Ricky Dhaliwal, MD Educational Pearls: Esophageal food impaction can be managed in the ED prior to calling GI for endoscopy Coca-cola, glucagon, benzodiazepines, calcium channel blockers, and dissolved nitroglycerin are all options to try For pediatric patients, weighted bougies can be used under sedation to attempt retrieval of the food bolus  Always evaluate airway status, especially if the patient cannot maintain secretions References Long B, Koyfman A, Gottlieb M. Esophageal Foreign Bodies and Obstruction in the Emergency Department Setting: An Evidence-Based Review. J Emerg Med. 2019;56(5):499-511. doi:10.1016/j.jemermed.2019.01.025 Khayyat YM. Pharmacological management of esophageal food bolus impaction. Emerg Med Int. 2013;2013:924015. doi:10.1155/2013/924015 Schimmel J, Slauson S. Swallowed Nitroglycerin to Treat Esophageal Food Impaction. Ann Emerg Med. 2019;74(3):462-463. doi:10.1016/j.annemergmed.2019.04.003 Summarized by John Spartz, MS4 | Edited by Erik Verzemnieks, MD   The Emergency Medical Minute is excited to announce that we are now offering AMA PRA Category 1 credits™ via online course modules. To access these and for more information, visit our website at https://emergencymedicalminute.org/cme-courses/ and create an account.  Donate to EMM today!

Daily cardiology
Electrical versus pharmacological cardioversion for acute AF in emergency settings

Daily cardiology

Play Episode Listen Later Jan 15, 2022 2:24


The Senior Care Pharmacist Podcast
Delirium and its Pharmacological Causes in Older People, Part Two

The Senior Care Pharmacist Podcast

Play Episode Listen Later Dec 13, 2021 17:10


Delirium is a syndrome that can arise from many causes or underlying conditions, and though it has been reported in younger patients, it is more prevalent in older people, though it can occur in other age groups as well. Identifying delirium is challenging in older people because of the coexistence of underlying dementia or depression, which may further complicate the presentation. Drug-induced delirium is one of the major causes of delirium, and evaluation of this potential cause or contribution is an important component of the evaluation process, since it can lead to poor patient outcomes. Part one of this three part series reviewed the epidemiology, pathophysiology, evaluation, diagnostic process, and causes of delirium in older people, with a focus on the pharmacological causes. Part two of this series continues to review drugs and drug classes that can cause or contribute to delirium in older people.

Reach Radio
Hypnosis, a Non-pharmacological Option for Pain Management with Roberta Fernandez & Ron Eslinger

Reach Radio

Play Episode Listen Later Sep 29, 2021 37:12


In this episode, you will enjoy listening to two of the most outstanding speakers in the hypnosis and pain management field. Roberta was one of Ron's students years ago! She has, since then, published a book, and he has kept working training Navy, Army, and Airforce nurses and doctors in hypnosis to treat patients before and after surgery. When you have and create happy experiences, our brains change too, and we can relive those moments. Hypnotism is about connecting with the person that's in the chair right in front of you. There's also a distinction between hypnotherapy and hypnosis. Hypnotists are gaining more and more recognition lately, and there are some great ones out there that base their work on science and research. Hypnosis is not a magical power to control minds; it opens you to receive suggestions to think things differently. For the full transcript and show notes, visit us at reachtl.org. --- Support this podcast: https://anchor.fm/fran-ayalasomayajula/support

The MCG Pediatric Podcast
Neonatal Opioid Withdrawal Syndrome

The MCG Pediatric Podcast

Play Episode Listen Later Sep 15, 2021 23:19


Join medical student Rilee Racine and Dr. Brian Stansfield, a neonatologist at the Children's Hospital of Georgia discuss Neonatal Opioid Withdrawal Syndrome, also known as NOWS.  After listening to this podcast, learners should be able to: Define neonatal opioid withdrawal syndrome Apply knowledge of signs and symptoms of NOWS to recognize these infants early Demonstrate general understanding of non-pharmacologic vs. pharmacologic management indications Recall the long term effects of NOWS and utilize this information to care for these infants long-term Educate families on clinical symptoms, management, and potential complications of NOWS Peer Review by Dr. Rebecca Yang and Dr. Amy Thompson Free CME Credit (requires sign-in): LINK COMING SOON Thank you for listening to this episode from the Department of Pediatrics at the Medical College of Georgia. If you have any comments, suggestions, or feedback- you can email us at mcgpediatricpodcast@augusta.edu. Remember that all content during this episode is intended for informational and educational purposes only. It should not be used as medical advice to diagnose or treat any particular patient. Clinical vignette cases presented are based on hypothetical patient scenarios. References: Anbalagan S, Mendez MD. Neonatal Abstinence Syndrome. 2020 Oct 1. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan–. PMID: 31855342. Armbruster, Debra PhD, APRN-CNP, NNP-BC, CPNP-PC, C-ELBW; Schwirian, Caitlyn PharmD; Mosier, Ashley MS, RN, CNL; Tam, Wai-Yin Mandy PharmD, BCPS, BCCCP; Prusakov, Pavel PharmD, BCPS, BCPPS Neonatal Abstinence Syndrome and Preterm Infants, Advances in Neonatal Care: March 05, 2021 - Volume Publish Ahead of Print - Issue - doi: 10.1097/ANC.0000000000000858 Finnegan LP. Neonatal abstinence syndrome: assessment and pharmacotherapy. In: Nelson N, editor. Current therapy in neonatal-perinatal medicine. 2 ed. Ontario: BC Decker; 1990. Jansson, Lauren M. MD. Neonatal abstinence syndrome. Uptodate. (2020). Johnson MR, Nash DR, Laird MR, Kiley RC, Martinez MA. Development and implementation of a pharmacist-managed, neonatal and pediatric, opioid-weaning protocol. J Pediatr Pharmacol Ther. 2014 Jul;19(3):165-73. doi: 10.5863/1551-6776-19.3.165. PMID: 25309146; PMCID: PMC4187529. Maguire, Denise J, PhD,R.N., C.N.L., Taylor, Susan, MSW,L.C.S.W.-C., C.M.A., Armstrong, K., PhD., Shaffer-Hudkins, E., Germain, A. M., M.D., Brooks, Sandra S,M.D., M.P.H., . . . Clark, L. (2016). Long-term outcomes of infants with neonatal abstinence syndrome: NN. Neonatal Network, 35(5), 277-286. doi:http://dx.doi.org/10.1891/0730-0832.35.5.277 Mangat, A. K., Schmölzer, G. M., & Kraft, W. K. (2019). Pharmacological and non-pharmacological treatments for the Neonatal Abstinence Syndrome (NAS). Seminars in fetal & neonatal medicine, 24(2), 133–141. https://doi.org/10.1016/j.siny.2019.01.009 Merhar SL, Ounpraseuth S, Devlin LA, Poindexter BB, Young LW, Berkey SD, Crowley M, Czynski AJ, Kiefer AS, Whalen BL, Das A, Fuller JF, Higgins RD, Thombre V, Lester BM, Smith PB, Newman S, Sánchez PJ, Smith MC, Simon AE; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT NEONATAL RESEARCH NETWORK AND THE NIH ENVIRONMENTAL INFLUENCES ON CHILD HEALTH OUTCOMES (ECHO) PROGRAM INSTITUTIONAL DEVELOPMENT AWARDS STATES PEDIATRIC CLINICAL TRIALS NETWORK. Phenobarbital and Clonidine as Secondary Medications for Neonatal Opioid Withdrawal Syndrome. Pediatrics. 2021 Mar;147(3):e2020017830. doi: 10.1542/peds.2020-017830. PMID: 33632932; PMCID: PMC7919109. Protecting Our Infants Act of 2015, H.R, 1462, 114th Cong. (2015-2016).  Sarka Lisonkova, Lindsay L. Richter, Joseph Ting, Giulia M. Muraca, Qi Wen, Azar Mehrabadi, Sheona Mitchell-Foster, Eugenia Oviedo-Joekes and Janet Lyons. Pediatrics August 2019, 144 (2) e20183664; DOI: https://doi.org/10.1542/peds.2018-3664 Siegler R., Saffran J., Eisenberg N., Deloache, J., & Gershoff, E. (2017). How Children Develop (5th ed.). NY, NY, USA: Macmillan Learning.  Stephen W. Patrick, Wanda D. Barfield, Brenda B. Poindexter and COMMITTEE ON FETUS AND NEWBORN, COMMITTEE ON SUBSTANCE USE AND PREVENTION. Neonatal Abstinence Withdrawal Syndrome. Pediatrics November 2020, 146 (5) e2020029074; DOI: https://doi.org/10.1542/peds.2020-029074 Patrick SW, Barfield WD, Poindexter BB; COMMITTEE ON FETUS AND NEWBORN, COMMITTEE ON SUBSTANCE USE AND PREVENTION. Neonatal Opioid Withdrawal Syndrome. Pediatrics. 2020 Nov;146(5):e2020029074. doi: 10.1542/peds.2020-029074. PMID: 33106341. Zimmermann, U., Rudin, C., Duò, A. et al. Treatment of opioid withdrawal in neonates with morphine, phenobarbital, or chlorpromazine: a randomized double-blind trial. Eur J Pediatr 179, 141–149 (2020). https://doi.org/10.1007/s00431-019-03486-6

Coptic Magical Papyri Podcast
Coptic Pharmacological Texts with Anne Grons

Coptic Magical Papyri Podcast

Play Episode Listen Later Aug 18, 2021 48:47


In this episode of the podcast, we are discussing Coptic pharmacological texts with Anne Grons, who is currently finishing her thesis on the topic. Pharmacological texts offer a window into ancient medical practices. The pharmacological prescriptions are aimed at healing various issues, often by applying remedies made of plants, animals, minerals or other substances, to the body. Coptic pharmacological texts are crucial for understanding Coptic magical prescriptions - often, the boundaries between the two genres are blurred, as they tend to use the same formulations or ingredients. Anne Grons has studied Egyptology and was the assistant/lexicographer at the project Dictionary and Database of Greek Loanwords in Coptic (DDGLC) (Freie Universität Berlin). Currently, she is a researcher at the Institute of the History of Pharmacy and Medicine (in formation) at Philipps-Universität Marburg led by Prof. Dr. Tanja Pommerening.

PsychNP Cast
Episode 2104: ASD in Youth - Erin Harrell, PMHNP

PsychNP Cast

Play Episode Listen Later Mar 28, 2021 56:49


Autism Spectrum Disorder with Erin Harrell Show NotesGuest: Erin Harrell, PMHNP https://www.infocuspsych.com/ (https://www.infocuspsych.com/) Southhaven, MS 38672 frontoffice@infocuspsych.com Autism screening testsThe Modified Checklist for Autism in Toddlers M-CHART https://www.autismspeaks.org/screen-your-child (https://www.autismspeaks.org/screen-your-child) Autism Behavior Checklist https://wbma.cc/wp-content/uploads/2018/04/ABC_checklist.pdf (https://wbma.cc/wp-content/uploads/2018/04/ABC_checklist.pdf) Autism Spectrum Quotient https://psychology-tools.com/test/autism-spectrum-quotient (https://psychology-tools.com/test/autism-spectrum-quotient) (online) https://psychcentral.com/quizzes/autism-test (https://psychcentral.com/quizzes/autism-test) (print) Childhood autism spectrum test (CAST) https://psychology-tools.com/test/cast (https://psychology-tools.com/test/cast) (online) https://www.autismresearchcentre.com/tests/childhood-autism-spectrum-test-cast/ (https://www.autismresearchcentre.com/tests/childhood-autism-spectrum-test-cast/) (print) ABA Therapy:ABA Therapy defined: https://www.autismspeaks.org/applied-behavior-analysis-aba-autism-treatment (https://www.autismspeaks.org/applied-behavior-analysis-aba-autism-treatment) ASD Organizations: National Autism Association: https://nationalautismassociation.org/ (https://nationalautismassociation.org/) Autism Society: https://www.autism-society.org/ (https://www.autism-society.org/) Autism Speaks: https://www.autismspeaks.org/ (https://www.autismspeaks.org/) Clinical Autism Books: Uniquely Human (A Different Way of Seeing Autism) https://amzn.to/3lRZFPq (https://amzn.to/3lRZFPq) Essential Clinical Guide to Understanding and Treating Autism https://amzn.to/3tVdnnE (https://amzn.to/3tVdnnE) Treating Disruptive Disorders: A Guide to Psychological, Pharmacological, and Combined Therapies https://amzn.to/3lQvQPr (https://amzn.to/3lQvQPr) A Clinician's Guide to Mental Health Conditions in Adults with Autism Spectrum Disorders https://amzn.to/31l8tEg (https://amzn.to/31l8tEg) AAP Pediatric Resources: Promoting Optimal Development: Identifying Infants and Young Children With Developmental Disorders Through Developmental Surveillance and Screening https://pediatrics.aappublications.org/content/145/1/e20193449 (https://pediatrics.aappublications.org/content/145/1/e20193449) AAP Autism Toolkit: https://toolkits.solutions.aap.org/autism/home https://www.aappublications.org/news/2019/12/16/autism121619 (https://www.aappublications.org/news/2019/12/16/autism121619) Contact PsychNP CastWant to be a guest? Fill this form out: https://forms.gle/tTQ8nChFaV4tKEj38 (https://forms.gle/tTQ8nChFaV4tKEj38) Email us Email: PsychNPcast@gmail.com

GI Insights
The Pharmacological Perspective: Treatment Options & the 2020 IBS Guidelines

GI Insights

Play Episode Listen Later Feb 26, 2021


Host: Neilanjan Nandi, MD Guest: Brian E. Lacy, MD, PhD What do we need to know about choosing the right medication for our patients with IBS? Stay tuned as Dr. Neil Nandi talks with Dr. Brain Lacy, a gastroenterologist at the Mayo Clinic, Jacksonville, and the co-editor-in-chief of the American Journal of Gastroenterology, on these pharmacologic therapies.

Our Odd Pod Podcast
A Pharmacological Case for Zombies

Our Odd Pod Podcast

Play Episode Listen Later Feb 19, 2021 54:20


How do you do that voodoo that you do? Join us this week as we attempt to tackle the subject of those brain eating bad boys... ZOMBIES!

Primary Care Anywhere
Ep. 7: Pharmacological Management of Weight Loss

Primary Care Anywhere

Play Episode Listen Later Feb 18, 2021 22:43


This is Episode 7 of Primary Care Anywhere, a resident-led podcast brought to you by the University of Utah Internal Medicine Residency. This episode focuses on pharmacological management in the treatment of obesity and features John Sanchez, MD-PhD candidate, Class of 2022; PGY-1 Austin Poth, PGY-2 Greg Toy, PGY-1 Alex Ryden, hosted by PGY-1 Kim Kucharski with infographics by PGY-2 Kasey Stoutin and show notes by PGY-1 Wes Cubberley, edited and produced by CMR Catey Harwell.

NURSING.com NCLEX® Question of the Day (Nursing Podcast for NCLEX® Prep and Nursing School) by NURSING.com (NRSNG)

The post QOD 097: Adult viral infection (Pharmacological and Parenteral Therapies) appeared first on NURSING.com.

NURSING.com NCLEX® Question of the Day (Nursing Podcast for NCLEX® Prep and Nursing School) by NURSING.com (NRSNG)

The post QOD 093: Adult hypertension (Pharmacological and Parenteral Therapies) appeared first on NURSING.com.

NURSING.com NCLEX® Question of the Day (Nursing Podcast for NCLEX® Prep and Nursing School) by NURSING.com (NRSNG)

The post QOD 081: Adult iv fluids (Pharmacological and Parenteral therapies) appeared first on NURSING.com.